Portfolio of Renaissance Technologies
Renaissance Technologies was founded by Jim Simons († 2024) and makes investment decisions with mathematical models; the portfolio holds a very large number of stocks.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 11, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 80.4B USD
- Positions
- 3,860
- Share of the ten largest
- 11.6%
The ten largest positions Q4 2021
- Novo Nordisk (ADR) 2.7%▼ −11.7%
- Atlassian 1.4%▼ −8.7%
- Verisign 1.3%▼ −10.2%
- Kroger 1.0%▼ −5.0%
- Microsoft 1.0%▼ −21.2%
- Tesla, Inc. 1.0%▼ −8.7%
- Zoom Video Communications In 0.9%▲ +24.5%
- Gilead Sciences 0.8%▲ +65.1%
- United Therapeutics Corp Del 0.8%▼ −3.7%
- Monster Beverage 0.8%▼ −6.0%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| NVO Novo Nordisk (ADR) | 2.7% | 19,116,871 | 2.1B USD | −11.7% reduced | Q2 2013 or earlier 35 quarters |
| TEAM Atlassian | 1.4% | 2,903,320 | 1.1B USD | −8.7% reduced | Q2 2016 23 quarters |
| VRSN Verisign | 1.3% | 4,149,890 | 1.1B USD | −10.2% reduced | Q2 2013 or earlier 35 quarters |
| KR Kroger | 1.0% | 17,650,310 | 798.9M USD | −5.0% reduced | Q2 2019 11 quarters |
| MSFT Microsoft | 1.0% | 2,336,398 | 785.8M USD | −21.2% reduced | Q3 2020 6 quarters |
| TSLA Tesla, Inc. | 1.0% | 743,475 | 785.7M USD | −8.7% reduced | Q4 2018 13 quarters |
| United Therapeutics Corp Del | 0.8% | 2,917,191 | 630.3M USD | −3.7% reduced | Q2 2013 or earlier 35 quarters |
| MNST Monster Beverage | 0.8% | 6,496,560 | 623.9M USD | −6.0% reduced | Q1 2014 32 quarters |
| HSY Hershey Company (The) | 0.8% | 3,184,386 | 616.1M USD | −2.5% reduced | Q2 2013 or earlier 35 quarters |
| Molina Healthcare Inc | 0.8% | 1,911,315 | 608.0M USD | −6.7% reduced | Q2 2013 or earlier 35 quarters |
| Franco Nev Corp | 0.7% | 4,122,903 | 570.2M USD | −8.8% reduced | Q1 2014 32 quarters |
| DPZ Domino's | 0.7% | 955,878 | 539.4M USD | −28.0% reduced | Q2 2013 or earlier 35 quarters |
| Abiomed Inc | 0.6% | 1,451,300 | 521.3M USD | −7.2% reduced | Q1 2015 28 quarters |
| MRNA Moderna | 0.6% | 1,833,722 | 465.7M USD | −8.3% reduced | Q4 2020 5 quarters |
| Icon PLC | 0.5% | 1,417,758 | 439.1M USD | −8.8% reduced | Q2 2013 or earlier 35 quarters |
| Vodafone Group PLC New | 0.5% | 26,050,832 | 388.9M USD | −8.8% reduced | Q3 2015 26 quarters |
| TGT Target Corporation | 0.5% | 1,656,720 | 383.4M USD | −46.3% reduced | Q1 2019 12 quarters |
| FTNT Fortinet | 0.5% | 1,012,789 | 364.0M USD | −4.4% reduced | Q3 2015 26 quarters |
| VRTX Vertex Pharmaceuticals | 0.4% | 1,626,868 | 357.3M USD | −14.0% reduced | Q1 2017 20 quarters |
| National Grid PLC | 0.4% | 4,925,268 | 356.2M USD | −4.6% reduced | Q2 2017 19 quarters |
| Herbalife Nutrition Ltd | 0.4% | 8,394,564 | 343.6M USD | −4.0% reduced | Q3 2015 26 quarters |
| AZN AstraZeneca | 0.4% | 5,818,828 | 338.9M USD | −15.5% reduced | Q1 2019 12 quarters |
| FFIV F5, Inc. | 0.4% | 1,361,062 | 333.1M USD | −11.5% reduced | Q3 2014 30 quarters |
| BMY Bristol Myers Squibb | 0.4% | 5,040,786 | 314.3M USD | −29.2% reduced | Q2 2016 23 quarters |
| Exelixis Inc | 0.4% | 17,100,778 | 312.6M USD | −2.5% reduced | Q3 2016 22 quarters |
| Cboe Global Mkts Inc | 0.4% | 2,310,824 | 301.3M USD | −5.9% reduced | Q2 2013 or earlier 35 quarters |
| ABBV AbbVie | 0.3% | 2,053,577 | 278.1M USD | −0.8% reduced | Q1 2018 16 quarters |
| Horizon Therapeutics Pub L | 0.3% | 2,277,066 | 245.4M USD | −30.0% reduced | Q2 2019 11 quarters |
| PG Procter & Gamble | 0.3% | 1,420,118 | 232.3M USD | −16.4% reduced | Q1 2020 8 quarters |
| CLX Clorox | 0.3% | 1,287,130 | 224.4M USD | −0.5% reduced | Q2 2013 or earlier 35 quarters |
| Jazz Pharmaceuticals PLC | 0.3% | 1,700,509 | 216.6M USD | −14.9% reduced | Q2 2015 27 quarters |
| Dropbox Inc | 0.3% | 8,446,333 | 207.3M USD | −12.0% reduced | Q1 2019 12 quarters |
| GE GE Aerospace | 0.3% | 2,174,079 | 205.4M USD | −10.2% reduced | Q1 2019 12 quarters |
| PEP PepsiCo | 0.2% | 1,141,062 | 198.2M USD | −33.5% reduced | Q1 2021 4 quarters |
| Cable One Inc | 0.2% | 110,800 | 195.4M USD | −13.6% reduced | Q4 2015 25 quarters |
| CL Colgate-Palmolive | 0.2% | 2,261,386 | 193.0M USD | −33.6% reduced | Q2 2013 or earlier 35 quarters |
| National Beverage Corp | 0.2% | 4,242,944 | 192.3M USD | −1.7% reduced | Q2 2013 or earlier 35 quarters |
| Corvel Corp | 0.2% | 902,210 | 187.7M USD | −4.9% reduced | Q2 2013 or earlier 35 quarters |
| PSA Public Storage | 0.2% | 490,608 | 183.8M USD | −1.0% reduced | Q2 2016 23 quarters |
| AZO AutoZone | 0.2% | 87,400 | 183.2M USD | −8.0% reduced | Q3 2021 2 quarters |
| Sprouts Fmrs Mkt Inc | 0.2% | 5,770,332 | 171.3M USD | −2.1% reduced | Q2 2016 23 quarters |
| Mobile Telesystems Pub Jt St | 0.2% | 21,169,574 | 168.3M USD | −0.2% reduced | Q3 2014 30 quarters |
| Medifast Inc | 0.2% | 797,610 | 167.0M USD | −5.1% reduced | Q2 2013 or earlier 35 quarters |
| Fortis Inc | 0.2% | 3,453,861 | 166.7M USD | −7.0% reduced | Q4 2016 21 quarters |
| Firstservice Corp New | 0.2% | 833,788 | 163.8M USD | −0.4% reduced | Q2 2019 11 quarters |
| Nova Ltd | 0.2% | 1,101,486 | 161.4M USD | −5.4% reduced | Q2 2013 or earlier 35 quarters |
| KDP Keurig Dr Pepper | 0.2% | 4,333,061 | 159.7M USD | −4.0% reduced | Q2 2019 11 quarters |
| Cogent Communications HLDGS | 0.2% | 2,178,356 | 159.4M USD | −2.7% reduced | Q2 2013 or earlier 35 quarters |
| Corcept Therapeutics Inc | 0.2% | 8,023,616 | 158.9M USD | −2.7% reduced | Q1 2015 28 quarters |
| NKE Nike, Inc. | 0.2% | 906,584 | 151.1M USD | −74.7% reduced | Q1 2021 4 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 1,629 positions.
Breakdown by sector
- Technology 8.3%
- Health Care 6.6%
- Consumer Staples 6.3%
- Consumer Discretionary 4.8%
- Financials 4.2%
- Industrials 3.5%
- Communication Services 3.2%
- Energy 1.7%
- Utilities 1.4%
- Materials 1.1%
- Real Estate 0.9%
- not in our coverage 58.0%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors